Konstantin H. Dragnev, MD, is Professor of Medicine, Medical Oncology, at Dartmouth Health. He is the Associate Director for Clinical Research at the Dartmouth Cancer Center, a NCI-designated Comprehensive Cancer Center. Dr. Dragnev specializes in the diagnosis and treatment of solid tumors. His special research interests are in the treatment and prevention of lung cancer, molecular mechanisms of lung carcinogenesis, clinical trial design, and evaluation of new agents for treatment of lung cancer. Dr. Dragnev is the Principal Investigator of several studies evaluating novel approaches for the treatment of lung cancer using immunotherapy and molecularly targeted agents.